Coenzyme Q10 and Cancer
In the late 1990s, observational studies showed that individuals with breast cancer, cancer of the pancreas, and lung cancer had lower plasma CoQ10 concentrations than healthy control individuals did. However, there have not been many clinical studies of Coenzyme Q10 as a therapeutic agent for the prevention or treatment of cancer.
In the ANICA breast cancer trial, Coenzyme Q10, as the primary agent in an antioxidant cocktail, showed promise as a treatment option. In an end-stage cancer trial, Coenzyme Q10 in combination with other antioxidants increased the survival period for 76% of the study participants. In other clinical studies, though, Coenzyme Q10 administration was not associated with reduced fatigue or with better quality of life in breast cancer patients and chemotherapy patients. More clinical research is needed.
Newest Articles About CoQ10 and Cancer
Coenzyme Q10 and Cancer Prevention and Treatment
In cancer prevention, Coenzyme Q10 supplements have antioxidant and anti-inflammatory properties that can help inhibit mutations in nuclear DNA. Once cancer has developed, studies of CoQ10 supplementation show either positive outcomes or no adverse effects on cancer progression.
Coenzyme Q10 and breast cancer care: a new review
Individuals with breast cancer are much more likely to have low plasma Coenzyme Q10 concentrations than healthy individuals. Cell line studies, animal studies, and a few human studies suggest that Coenzyme Q10 supplementation [...]
End-of-the-year Coenzyme Q10 performance report card
Coenzyme Q10 as a nutritional supplement – if properly formulated – gets an A grade for performance. Coenzyme Q10 goes right to the head of the class on our list of daily nutritional supplements, [...]
